Long-Term Outcomes of Additional Surgery After Endoscopic Resection Versus Primary Surgery for T1 Colorectal Cancer.
Yuzuru TamaruToshio KuwaiYoshiki KajiwaraShiro OkaShoichi SaitoYosuke FukunagaHiroshi KawachiManabu TakamatsuKinichi HottaHiroaki IkematsuMotohiro KojimaYutaka SaitoYukihide KanemitsuMasayoshi YamadaShigeki SekineShinji TanakaShinji NagataTakahiro NakamuraKazutaka YamadaMaki KonnoSoichiro IshiharaYusuke SaitohKenji MatsudaKazutomo TogashiKoji KomoriMegumi IshiguroTakashi OkuyamaAkihiro OhuchiShinobu OhnumaKazuhiro SakamotoTamotsu SugaiKenji KatsumataHiro-O MatsushitaHiro-O YamanoKeisuke NakaiMasashi NamikawaNaohiko AkimotoHirotoshi KobayashiYoichi AjiokaKenichi SugiharaHideki UenoPublished in: The American journal of gastroenterology (2024)
ER before AS for T1 CRC had no adverse effect on patients' long-term outcomes, including the 5-year OS rate. ER is a viable first-line treatment option for endoscopically resectable T1 CRC.
Keyphrases
- minimally invasive
- end stage renal disease
- coronary artery bypass
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- estrogen receptor
- prognostic factors
- surgical site infection
- emergency department
- squamous cell carcinoma
- locally advanced
- radiation therapy
- acute coronary syndrome
- adverse drug